Antibacterial photodynamic
therapy (aPDT) utilizes reactive oxygen
species such as singlet oxygen (
1
O
2
) and free
radicals via photosensitizers, which are light and light-sensitive
agents, to reduce bacterial infections. It has been utilized as a
treatment for dental diseases in place of antibiotic therapies. However,
aPDT does not always cause the desired therapeutic effect due to the
instability of organic photosensitizers and the formation of bacterial
biofilms. To promote the antibacterial and antibiofilm effects of
aPDT, we have proposed a lysozyme (Lys)-gold nanoclusters (Au NCs)/rose
bengal (Lys-Au NCs/RB) conjugate as a novel photosensitizer. This
conjugate was found to effectively impede the growth of both gram-positive
and gram-negative bacteria when exposed to white light-emitting diode
(LED) irradiation. The photoexcited Lys-Au NCs/RB showed significantly
higher antibacterial activity than photoexcited Lys-Au NCs or RB alone.
The synergistic effect is a result of the combination of Lys (an antibacterial
protein) and enhanced
1
O
2
generation related
to resonance energy transfer (RET) in the Au NCs/RB conjugate. Photoexcited
Lys-Au NCs/RB increased the effects of aPDT in a dose- and time-dependent
manner. Furthermore, the photoexcited Lys-Au NCs/RB successfully decreased
Streptococcus mutans
biofilm formation. However,
in contrast, it did not have a negative effect on the proliferation,
adhesion, or spread of mammalian cells, indicating low cytotoxicity.
Lys-Au NCs/RB is a novel photosensitizer with low cytotoxicity that
is capable of bacterial inactivation and the suppression of biofilm
formation, and could help to improve dental treatments in the future.